![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
Oxygen Biotherapeutics and Sarasota Medical Products Sign Binding Letter of Intent to Pursue Joint Research and Development in Chronic Ischemic Wound Care
December 16, 2010 02:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Dec. 16, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) and privately held Sarasota Medical Products, Inc. (SMP) of Sarasota, FL, today...
![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
Oxygen Biotherapeutics Reports Second Quarter FY2011 Financial Results
December 09, 2010 18:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Dec. 9, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...
![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
Oxygen Biotherapeutics Awarded $244,479 Grant Under the Patient Protection and Affordable Care Program
November 02, 2010 02:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Nov. 2, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced it has received nearly $245,000 in a grant under the Patient...
![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
DERMACYTE(R) Skin Care Products Secure Key Listing on DermStore.com, a Leading Dermatologic and Beauty E-tail Web Site
October 20, 2010 08:30 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Oct. 20, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced DERMACYTE® skin care products are now available for purchase...
![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
DERMACYTE(R) Skin Care Products Secure Major Listing on BeautyRiche.com, a Leading Dermatologic and Beauty E-Tail Web Site
October 19, 2010 08:30 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Oct. 19, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced DERMACYTE® skin care products are now available for purchase...
![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
Oxygen Biotherapeutics Enters Into Purchase Agreement to Sell $5 Million of Unsecured Promissory Notes to Vatea Fund
October 13, 2010 10:31 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Oct. 13, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) entered into a Note Purchase Agreement with JP SPC 1 Vatea, Segregated Portfolio...
![Oxygen Biotherapeutics, Inc. Logo](http://www.globenewswire.com/en/Attachment/LogoDisplay/218847?filename=218847.jpg&size=2)
Oxygen Biotherapeutics to Showcase New DERMACYTE(R) Oxygen-Enriched Lotions at Leading Spa and Resort Conference in New York City
September 27, 2010 10:30 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Sept. 27, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) will showcase for the first time its DERMACYTE oxygen-rich skin care products at...
![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
Oxygen Biotherapeutics Receives DSMB Approval to Proceed to the Next Cohort in Its Phase II-B Clinical Trial for Traumatic Brain Injury
September 23, 2010 02:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Sept. 23, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) reported today that the Data Safety Monitoring Board overseeing the company's...
![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
U.S. Navy Broadens CRADA With Oxygen Biotherapeutics to Include Preclinical Studies Assessing Oxycyte(R) for Spinal Cord Injury Due to Decompression Sickness and for Hemorrhagic Shock
September 20, 2010 02:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Sept. 20, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced it has amended an existing Cooperative Research and Development...
![Oxygen Biotherapeutics, Inc. Logo](/news-release/logo/218847/0/218847.jpg?lastModified=12%2F09%2F2016%2023%3A28%3A07&size=2)
Oxygen Biotherapeutics Reports First Quarter FY2011 Financial Results
September 09, 2010 20:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Sept. 9, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...